Related references
Note: Only part of the references are listed.COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity
Nan Sang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol
Bela Szabo et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Lipid signaling and synaptic plasticity
Nan Sang et al.
NEUROSCIENTIST (2006)
Protective activation of the endocannabinoid system during ischemia in dopamine neurons
Miriam Melis et al.
NEUROBIOLOGY OF DISEASE (2006)
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection
Leyre Mestre et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies
Allyn C. Howlett et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
The endocannabinoid system controls key epileptogenic circuits in the hippocampus
Krisztina Monory et al.
NEURON (2006)
Molecular composition of the endocannabinoid system at glutamatergic synapses
István Katona et al.
JOURNAL OF NEUROSCIENCE (2006)
Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor
T Yoshida et al.
JOURNAL OF NEUROSCIENCE (2006)
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
D Panikashvili et al.
NEUROBIOLOGY OF DISEASE (2006)
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
RL Suplita et al.
NEUROPHARMACOLOGY (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells
E Eljaschewitsch et al.
NEURON (2006)
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones
A Straiker et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance
GA Cabral et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Endocannabinoids control the induction of cerebellar LTD
PK Safo et al.
NEURON (2005)
Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor
N Sang et al.
JOURNAL OF NEUROSCIENCE (2005)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Lipid signaling: Sleep, synaptic plasticity, and neuroprotection
C Chen et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2005)
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
JK Makara et al.
NATURE NEUROSCIENCE (2005)
Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels
L De Petrocellis et al.
LIFE SCIENCES (2005)
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann et al.
NATURE (2005)
The endocannabinoid signalling system: Biochemical aspects
T Bisogno et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
New insights into COX-2 biology and inhibition
P Patrignani et al.
BRAIN RESEARCH REVIEWS (2005)
CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition
D Panikashvili et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury
JJ Gopez et al.
NEUROSURGERY (2005)
Cannabinoid receptors and their role in neuroprotection
M van der Stelt et al.
NEUROMOLECULAR MEDICINE (2005)
Cannabinoids: Between Neuroprotection and Neurotoxicity
Yosef Sarne et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2005)
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism
EJ Carrier et al.
MOLECULAR PHARMACOLOGY (2004)
Cannabinoids and neuroinflammation
L Walter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase
L Walter et al.
JOURNAL OF NEUROSCIENCE (2004)
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus
J Kim et al.
NATURE NEUROSCIENCE (2004)
Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons
M Melis et al.
JOURNAL OF NEUROSCIENCE (2004)
Oxidative metabolism of endocannabinoids by COX-2
KR Kozak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels
M van der Stelt et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Role of endogenous cannabinoids in synaptic signaling
TF Freund et al.
PHYSIOLOGICAL REVIEWS (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
Anandamide and vanilloid TRPV1 receptors
RA Ross
BRITISH JOURNAL OF PHARMACOLOGY (2003)
CB1 cannabinoid receptor-G protein association:: a possible mechanism for differential signaling
S Mukhopadhyay et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2002)
Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Brain monoglyceride lipase participating in endocannabinoid inactivation
TP Dinh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclooxygenase inhibition as a strategy to ameliorate brain injury
SD Hurley et al.
JOURNAL OF NEUROTRAUMA (2002)
Differential roles of cyclooxygenase isoforms after kainic acid-induced prostaglandin E2 production and neurodegeneration in cortical and hippocampal cell cultures
EJ Kim et al.
BRAIN RESEARCH (2001)
The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus
T Kunz et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice
C Ladecola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
YH Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Kainic acid rapidly induces cyclooxygenase (COX)-2 in piglet cerebral cortex
F Domoki et al.
NEUROREPORT (2000)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
